The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases-Reference-Cited by-同舟云学术

The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases

Published:2014-03 Issue:5 Volume:50 Page:972-980
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Schiavon Gaia,Ruggiero Alessandro,Bekers Dave J.,Barry Peter A.,Sleijfer Stefan,Kloth Jaqueline,Krestin Gabriel P.,Schöffski Patrick,Verweij Jaap,Mathijssen Ron H.J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

2. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000

3. RECIST revisited: a review of validation studies on tumour assessment;Therasse;Eur J Cancer,2006

4. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO, Publication No. 48; 1979. p. 45.

5. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study;van Oosterom;Lancet,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study;Molecular Oncology;2024-05-24

2. RECIST 1.1 Target Lesion Categorical Response in Metastatic Renal Cell Carcinoma: A Comparison of Conventional versus Volumetric Assessment;Radiology: Imaging Cancer;2023-09-01

3. Early on-treatment tumor growth rate (EOT-TGR) determines treatment outcomes of advanced non-small-cell lung cancer patients treated with programmed cell death protein 1 axis inhibitor;ESMO Open;2022-12

4. Early Prediction and Monitoring of Treatment Response in Gastrointestinal Stromal Tumors by Means of Imaging: A Systematic Review;Diagnostics;2022-11-07

5. Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 ‘CaboGIST’;Acta Oncologica;2022-04-28